Five amazing things: astronomy

The best of the web, brought to you.

The best of the web, brought to you.

The internet is full of astonishing videos, pictures and articles but the noise-to-signal ratio can be boringly high. So, from now on, I'll be regularly collecting five of the best texts, movies and images, old and new, on a variety of subjects.

This time: astronomy. Next time: dancing.

1. Scale by Brad Goodspeed

How big would the other planets look if they orbited the earth at the same distance -- 380,000km -- that the moon does? Brad Goodspeed's visualisation will show you. Watch out for Jupiter, which is intimidatingly vast.

2. Bill O'Reilly doesn't understand the moon

While we're talking about the moon, it turns out that Bill O'Reilly doesn't know how it works -- which is why he believes in God. "How did the moon get there?" he asks. "How come we have that, and Mars doesn't?" As I think Jon Stewart pointed out recently, O'Reilly seems to believe that if he doesn't understand a given concept, no one does. (By the way, Bill, National Geographic has the answer here.)

3. Eclipsing the sun

File this under "Eek". The French photographer Thierry Legault took a photo of the International Space Station passing in front of the sun. A humbling reminder that even our most cutting-edge technology is pretty small beer on the cosmic scale.

Oh, and if you want to see what the astronauts on the ISS are looking at right now, you can do that at the Nasa website here.

4. Nasa's astronomy picture of the day

Always beautiful, often mind-boggling, these photos have recently included the cracked surface of Jupiter's moon Europa, the deep-space contortions of the Seagull Nebula and gorgeous skies over Libya and Stockholm. Look out, too, for the amazing video of the Peerskill meteor of 1992, which, despite being only the size of a bowling ball, was brighter than a full moon as it screamed towards earth.

5. "Pale Blue Dot" by Carl Sagan

My final pick is a personal one: Carl Sagan's "Pale Blue Dot". We had this as a reading at our wedding, because its both humbling and hopeful. Starting with a photo of earth taken in 1990 by Voyager 1 from the edge of the solar system -- 3,781,782,502 miles away -- the great science educator reflects on our responsibility to care for that "mote of dust suspended in a sunbeam . . . the only home we've ever known". If you don't feel a little prickle in your tearducts by the end, you have no soul.

An image from NASA''s Hubble Space Telescope of a vast, sculpted landscape of gas and dust where thousands of stars are being born. Credit: Getty Images

Helen Lewis is deputy editor of the New Statesman. She has presented BBC Radio 4’s Week in Westminster and is a regular panellist on BBC1’s Sunday Politics.

Getty Images/ Staff
Show Hide image

The answer to the antibiotics crisis might be inside your nose

The medical weapons we have equipped ourselves with are losing their power. But scientists scent an answer. 

They say there’s a hero in everyone. It turns out that actually, it resides within only about ten percent of us. Staphylococcus lugdunensis may be the species of bacteria that we arguably don’t deserve, but it is the one that we need.

Recently, experts have cautioned that we may be on the cusp of a post-antibiotic era. In fact, less than a month ago, the US Centres for Disease Control and Prevention released a report on a woman who died from a "pan-resistant" disease – one that survived the use of all available antibiotics. Back in 1945, the discoverer of penicillin, Alexander Fleming, warned during his Nobel Prize acceptance speech against the misuse of antibiotics. More recently, Britain's Chief Medical Officer Professor Dame Sally Davies has referred to anti-microbial resistance as “the greatest future threat to our civilisation”.

However, hope has appeared in the form of "lugdunin", a compound secreted by a species of bacteria found in a rather unlikely location – the human nose.

Governments and health campaigners alike may be assisted by a discovery by researchers at the University of Tubingen in Germany. According to a study published in Nature, the researchers had been studying Staphylococcus aureus. This is the bacteria which is responsible for so-called "superbug": MRSA. A strain of MRSA bacteria is not particularly virulent, but crucially, it is not susceptible to common antibiotics. This means that MRSA spreads quickly from crowded locations where residents have weaker immune systems, such as hospitals, before becoming endemic in the wider local community. In the UK, MRSA is a factor in hundreds of deaths a year. 

The researchers in question were investigating why S. aureus is not present in the noses of some people. They discovered that another bacteria, S. lugdunensis, was especially effective at wiping out its opposition, even MRSA. The researchers named the compound created and released by the S. lugdunensis "lugdunin".

In the animal testing stage, the researchers observed that the presence of lugdunin was successful in radically reducing and sometimes purging the infection. The researchers subsequently collected nasal swabs from 187 hospital patients, and found S. aureus on roughly a third of the swabs, and S. lugdunensis on up to 10 per cent of them. In accordance with previous results, samples that contained both species saw an 80 per cent decrease of the S. aureus population, in comparison to those without lugdunin.

Most notably, the in vitro (laboratory) testing phase provided evidence that the new discovery is also useful in eliminating other kinds of superbugs, none of which seemed to develop resistance to the new compound. The authors of the study hypothesised that lugdunin had evolved  “for the purpose of bacterial elimination in the human organism, implying that it is optimised for efficacy and tolerance at its physiological site of action". How it works, though, is not fully understood. 

The discovery of lugdunin as a potential new treatment is a breakthrough on its own. But that is not the end of the story. It holds implications for “a new concept of finding antibiotics”, according to Andreas Peschel, one of the bacteriologists behind the discovery.

The development of antibiotics has drastically slowed in recent years. In the last 50 years, only two new classes of this category of medication have been released to the market. This is due to the fact almost all antibiotics in use are derived from soil bacteria. By contrast, the new findings record the first occurrence of a strain of bacteria that exists within human bodies. Some researchers now suggest that the more hostile the environment to bacterial growth, the more likely it may be for novel antibiotics to be found. This could open up a new list of potential areas in which antibiotic research may be carried out.

When it comes to beating MRSA, there is hope that lugdunin will be our next great weapon. Peschel and his fellow collaborators are in talks with various companies about developing a medical treatment that uses lugdunin.

Meanwhile, in September 2016, the United Nations committed itself to opposing the spread of antibiotic resistance. Of the many points to which the UN signatories have agreed, possibly the most significant is their commitment to “encourage innovative ways to develop new antibiotics”. 

The initiative has the scope to achieve a lot, or dissolve into box ticking exercise. The discovery of lugdunin may well be the spark that drives it forward. Nothing to sniff about that. 

Anjuli R. K. Shere is a 2016/17 Wellcome Scholar and science intern at the New Statesman